Ottimo raises $140mn in pursuit of ‘$100bn market’ for new cancer drugs
19 Dec 2024
Boss David Epstein hopes to replicate his success at Seagen after $43bn sale last year
Read full article at _Financial Times
19 Dec 2024
Boss David Epstein hopes to replicate his success at Seagen after $43bn sale last year
Read full article at _Financial Times